Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study
There is limited information on patterns of treatment change among new initiators of highly active antiretroviral therapy (HAART) in the regions most affected by HIV/AIDS. This makes it difficult to identify the determinants of treatment change. In this retrospective cohort study, we examined treatm...
Saved in:
Published in | BMC infectious diseases Vol. 17; no. 1; pp. 664 - 10 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
02.10.2017
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | There is limited information on patterns of treatment change among new initiators of highly active antiretroviral therapy (HAART) in the regions most affected by HIV/AIDS. This makes it difficult to identify the determinants of treatment change. In this retrospective cohort study, we examined treatment change patterns over a five-year period among initiators of HAART.
De-identified data were obtained from the Fevers' Unit Database at the Korle-Bu Teaching Hospital. All adult treatment-naive patients who started treatment with first line HAART between 1st January, 2008 and 31st December, 2012 were followed over a minimum period of three months. The main outcome was the first treatment change, defined as the first substitution/switch in accordance with the standard treatment guidelines. Data were analyzed stratified by year of treatment initiation. Crude and adjusted hazard ratios were calculated.
A total of 3933 patients were followed with almost equal numbers of initiators per year. The mean age (standard deviation) at treatment initiation was 39 (10.3) years. The most prescribed HAART combination was AZT/3TC/EFV and overall for initiators zidovudine combination therapy was about 60%. Utilization of stavudine containing HAART increased gradually until 2010 and then dropped to zero. Over the study period, 44.9% of recorded deaths were from those initiated with a stavudine backbone, 41.1% from a zidovudine backbone, and 11.5% from a tenofovir backbone. Females had a significantly higher rate of treatment change compared to males (p-value = 0.0002), and d4T/3TC/EFV and d4T/3TC/NVP recorded independent treatment change hazard ratios of 12.05 (CI 9.58 to 15.16) and 12.03 (CI 9.27 to 15.61) respectively.. Kaplan-Meier curves showed that treatment change was higher among those who started treatment later in the study period compared with those who started earlier.
A major treatment change in the utilization of antiretroviral medicines in Ghana occurred during the study period which was associated with type of treatment, year of treatment, gender and disease stage. The influence of a policy change during the period may have made a significant impact.. For diseases involving life-long treatment in particular, it is important to monitor and periodically evaluation treatment utilization patterns. |
---|---|
AbstractList | There is limited information on patterns of treatment change among new initiators of highly active antiretroviral therapy (HAART) in the regions most affected by HIV/AIDS. This makes it difficult to identify the determinants of treatment change. In this retrospective cohort study, we examined treatment change patterns over a five-year period among initiators of HAART.
De-identified data were obtained from the Fevers' Unit Database at the Korle-Bu Teaching Hospital. All adult treatment-naive patients who started treatment with first line HAART between 1st January, 2008 and 31st December, 2012 were followed over a minimum period of three months. The main outcome was the first treatment change, defined as the first substitution/switch in accordance with the standard treatment guidelines. Data were analyzed stratified by year of treatment initiation. Crude and adjusted hazard ratios were calculated.
A total of 3933 patients were followed with almost equal numbers of initiators per year. The mean age (standard deviation) at treatment initiation was 39 (10.3) years. The most prescribed HAART combination was AZT/3TC/EFV and overall for initiators zidovudine combination therapy was about 60%. Utilization of stavudine containing HAART increased gradually until 2010 and then dropped to zero. Over the study period, 44.9% of recorded deaths were from those initiated with a stavudine backbone, 41.1% from a zidovudine backbone, and 11.5% from a tenofovir backbone. Females had a significantly higher rate of treatment change compared to males (p-value = 0.0002), and d4T/3TC/EFV and d4T/3TC/NVP recorded independent treatment change hazard ratios of 12.05 (CI 9.58 to 15.16) and 12.03 (CI 9.27 to 15.61) respectively.. Kaplan-Meier curves showed that treatment change was higher among those who started treatment later in the study period compared with those who started earlier.
A major treatment change in the utilization of antiretroviral medicines in Ghana occurred during the study period which was associated with type of treatment, year of treatment, gender and disease stage. The influence of a policy change during the period may have made a significant impact.. For diseases involving life-long treatment in particular, it is important to monitor and periodically evaluation treatment utilization patterns. Abstract Background There is limited information on patterns of treatment change among new initiators of highly active antiretroviral therapy (HAART) in the regions most affected by HIV/AIDS. This makes it difficult to identify the determinants of treatment change. In this retrospective cohort study, we examined treatment change patterns over a five-year period among initiators of HAART. Methods De-identified data were obtained from the Fevers’ Unit Database at the Korle-Bu Teaching Hospital. All adult treatment-naive patients who started treatment with first line HAART between 1st January, 2008 and 31st December, 2012 were followed over a minimum period of three months. The main outcome was the first treatment change, defined as the first substitution/switch in accordance with the standard treatment guidelines. Data were analyzed stratified by year of treatment initiation. Crude and adjusted hazard ratios were calculated. Results A total of 3933 patients were followed with almost equal numbers of initiators per year. The mean age (standard deviation) at treatment initiation was 39 (10.3) years. The most prescribed HAART combination was AZT/3TC/EFV and overall for initiators zidovudine combination therapy was about 60%. Utilization of stavudine containing HAART increased gradually until 2010 and then dropped to zero. Over the study period, 44.9% of recorded deaths were from those initiated with a stavudine backbone, 41.1% from a zidovudine backbone, and 11.5% from a tenofovir backbone. Females had a significantly higher rate of treatment change compared to males (p-value = 0.0002), and d4T/3TC/EFV and d4T/3TC/NVP recorded independent treatment change hazard ratios of 12.05 (CI 9.58 to 15.16) and 12.03 (CI 9.27 to 15.61) respectively.. Kaplan-Meier curves showed that treatment change was higher among those who started treatment later in the study period compared with those who started earlier. Conclusion A major treatment change in the utilization of antiretroviral medicines in Ghana occurred during the study period which was associated with type of treatment, year of treatment, gender and disease stage. The influence of a policy change during the period may have made a significant impact.. For diseases involving life-long treatment in particular, it is important to monitor and periodically evaluation treatment utilization patterns. |
ArticleNumber | 664 |
Audience | Academic |
Author | Lartey, Margaret Mantel-Teeuwisse, Aukje K Leufkens, Hubert G M Ankrah, Daniel N A |
Author_xml | – sequence: 1 givenname: Daniel N A orcidid: 0000-0002-2447-1830 surname: Ankrah fullname: Ankrah, Daniel N A email: D.Ankrah@uu.nl, D.Ankrah@uu.nl organization: Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), PO Box 80082, 3508, TB, Utrecht, the Netherlands. D.Ankrah@uu.nl – sequence: 2 givenname: Margaret surname: Lartey fullname: Lartey, Margaret organization: University of Ghana Medical School, P. O. Box GP, 4236, Accra, Ghana – sequence: 3 givenname: Aukje K surname: Mantel-Teeuwisse fullname: Mantel-Teeuwisse, Aukje K organization: Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), PO Box 80082, 3508, TB, Utrecht, the Netherlands – sequence: 4 givenname: Hubert G M surname: Leufkens fullname: Leufkens, Hubert G M organization: Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), PO Box 80082, 3508, TB, Utrecht, the Netherlands |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28969591$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkktr3DAUhUVJaR7tD-imGLrKwoklv6QuCkPaJIZAoGmzFbJ05VEY24OkCZ1_3zvjJsSQRZBA4uo7R0j3HJODYRyAkM80O6OUV-eBMl6LNKN1yuqSpfU7ckSLmqYsz4uDF_tDchzCQ4YgZ-IDOWRcVKIU9IjES_cI6RaUT6KHwYTEDbudij0MMdFLNXSwLyqcZrPC2rgcfUxGm1w39-eL5sddslbRIb7nrlCiviUq8RD9GNagI17xpApxY7YfyXurVgE-_V9PyJ_Ln78vrtOb26vmYnGT6irLYloAhyLPWWkF11TnVtGcAmSGcm2EMdyWNeOMgbVlmxUMuDCWGSEQAOBtfkKaydeM6kGuveuV38pRObkvjL6TykenVyBV29ZUlVxpzouagdBFZgrQBdM8t5yh1_fJa71pezAan-vVamY6PxncUnbjoywrVpaCo8HXyaBTeJ8b7IiY7l3QclHSDLtR1TlSZ69QOAz0TmP7rcP6THA6EyAT4W_s1CYE2dz9ejt7ez9n6cRqbGLwYJ-fSjO5S5-c0icxVHKXPlmj5svLP3pWPMUt_wfQeNZA |
CitedBy_id | crossref_primary_10_1371_journal_pone_0227779 |
Cites_doi | 10.1371/journal.pone.0030647 10.1177/135965350701200508 10.1093/ije/dym211 10.1038/nrd1201 10.1097/QAI.0b013e31822a9f8d 10.4172/2155-6113.1000510 10.1001/jama.292.2.191 10.1016/j.coph.2010.04.011 10.1097/00002030-200310170-00012 10.1086/521150 10.1089/aid.2007.0219 10.1097/QAI.0b013e31817ae5ef 10.1097/00042560-199801001-00003 10.1186/1471-2334-14-90 10.1111/hiv.12055 10.1086/649884 10.1097/01.qai.0000137004.63376.27 10.1097/01.aids.0000233574.49220.de 10.1002/14651858.CD008651 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2017 BioMed Central Ltd. The Author(s). 2017 |
Copyright_xml | – notice: COPYRIGHT 2017 BioMed Central Ltd. – notice: The Author(s). 2017 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISR 5PM DOA |
DOI | 10.1186/s12879-017-2752-7 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Opposing Viewpoints In Context Gale In Context: Science PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2334 |
EndPage | 10 |
ExternalDocumentID | oai_doaj_org_article_abb71a58ac88472e9c40d4ec42c83f82 A510591673 10_1186_s12879_017_2752_7 28969591 |
Genre | Journal Article |
GeographicLocations | Ghana |
GeographicLocations_xml | – name: Ghana |
GroupedDBID | --- -A0 0R~ 23N 2WC 3V. 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX CITATION AFGXO ABVAZ AFNRJ 5PM |
ID | FETCH-LOGICAL-c600t-4e8e43325f98c1c3fa131ee0d18cd9dd8f572822eff5b042e89df2d99d18ee8b3 |
IEDL.DBID | RPM |
ISSN | 1471-2334 |
IngestDate | Fri Oct 04 13:06:22 EDT 2024 Tue Sep 17 21:24:53 EDT 2024 Fri Feb 23 00:16:05 EST 2024 Fri Feb 02 04:28:16 EST 2024 Thu Aug 01 19:41:35 EDT 2024 Thu Aug 01 19:29:56 EDT 2024 Thu Sep 12 18:51:46 EDT 2024 Wed Oct 16 00:59:35 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Database HIV/aids Policy change Ghana Utilization Trends |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c600t-4e8e43325f98c1c3fa131ee0d18cd9dd8f572822eff5b042e89df2d99d18ee8b3 |
ORCID | 0000-0002-2447-1830 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625598/ |
PMID | 28969591 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_abb71a58ac88472e9c40d4ec42c83f82 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5625598 gale_infotracmisc_A510591673 gale_infotracacademiconefile_A510591673 gale_incontextgauss_ISR_A510591673 gale_incontextgauss_IOV_A510591673 crossref_primary_10_1186_s12879_017_2752_7 pubmed_primary_28969591 |
PublicationCentury | 2000 |
PublicationDate | 2017-10-02 |
PublicationDateYYYYMMDD | 2017-10-02 |
PublicationDate_xml | – month: 10 year: 2017 text: 2017-10-02 day: 02 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC infectious diseases |
PublicationTitleAlternate | BMC Infect Dis |
PublicationYear | 2017 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 22303447 - PLoS One. 2012;7(1):e30647 21765366 - J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):e68-74 17879931 - Clin Infect Dis. 2007 Oct 15;45(8):1093-101 15249568 - JAMA. 2004 Jul 14;292(2):191-201 28638661 - AIDS Res Treat. 2017;2017:5792925 14523281 - AIDS. 2003 Oct 17;17(15):2237-44 18545151 - J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):334-44 17998242 - Int J Epidemiol. 2008 Oct;37(5):956-62 14526384 - Nat Rev Drug Discov. 2003 Oct;2(10):812-22 20043752 - Clin Infect Dis. 2010 Feb 1;50(3):416-25 24552395 - BMC Infect Dis. 2014 Feb 20;14:90 9586643 - J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17 Suppl 1:S4-8 18327976 - AIDS Res Hum Retroviruses. 2008 Mar;24(3):393-9 20471318 - Curr Opin Pharmacol. 2010 Oct;10(5):507-15 16791015 - AIDS. 2006 Jun 26;20(10):1407-14 15319667 - J Acquir Immune Defic Syndr. 2004 Sep 1;37 Suppl 1:S30-5 17713158 - Antivir Ther. 2007;12(5):753-60 2752_CR19 2752_CR16 2752_CR15 2752_CR5 2752_CR4 2752_CR3 2752_CR1 UNAIDS (2752_CR13) 2012 C Staehelin (2752_CR12) 2003; 17 RA Coutinho (2752_CR10) 1998; 17 E de Clercq (2752_CR2) 2010; 10 G Jouquet (2752_CR8) 2011; 58 G McComsey (2752_CR21) 2004; 37 MA Bender (2752_CR7) 2010; 50 D Ankrah (2752_CR18) 2015; 6 R Subbaraman (2752_CR20) 2007; 45 TL Dadi (2752_CR24) 2017; 2017 2752_CR27 2752_CR26 A Boulle (2752_CR6) 2007; 12 JE Gallant (2752_CR23) 2004; 292 S Rosen (2752_CR9) 2008; 48 C Laurent (2752_CR17) 2008; 24 F Tanser (2752_CR14) 2008; 37 V Phan (2752_CR28) 2012; 7 JM Llibre (2752_CR22) 2006; 20 2752_CR25 W Elamin (2752_CR11) 2013; 14 |
References_xml | – ident: 2752_CR26 – volume: 7 issue: 1 year: 2012 ident: 2752_CR28 publication-title: PLoS One doi: 10.1371/journal.pone.0030647 contributor: fullname: V Phan – ident: 2752_CR3 – ident: 2752_CR1 – volume: 12 start-page: 753 year: 2007 ident: 2752_CR6 publication-title: Antivir Ther doi: 10.1177/135965350701200508 contributor: fullname: A Boulle – ident: 2752_CR15 – volume: 2017 start-page: 5792925 year: 2017 ident: 2752_CR24 publication-title: AIDS Research and Treatment contributor: fullname: TL Dadi – ident: 2752_CR19 – volume: 37 start-page: 956 year: 2008 ident: 2752_CR14 publication-title: Int J Epidemiol doi: 10.1093/ije/dym211 contributor: fullname: F Tanser – volume-title: Global AIDS epidemic facts and figures, 2012: Geneva, Switzerland year: 2012 ident: 2752_CR13 contributor: fullname: UNAIDS – ident: 2752_CR5 doi: 10.1038/nrd1201 – volume: 58 start-page: e68 issue: 3 year: 2011 ident: 2752_CR8 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e31822a9f8d contributor: fullname: G Jouquet – volume: 6 start-page: 10 year: 2015 ident: 2752_CR18 publication-title: J AIDS Clin Res doi: 10.4172/2155-6113.1000510 contributor: fullname: D Ankrah – volume: 292 start-page: 191 year: 2004 ident: 2752_CR23 publication-title: JAMA doi: 10.1001/jama.292.2.191 contributor: fullname: JE Gallant – ident: 2752_CR4 – volume: 10 start-page: 507 issue: 5 year: 2010 ident: 2752_CR2 publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2010.04.011 contributor: fullname: E de Clercq – volume: 17 start-page: 2237 year: 2003 ident: 2752_CR12 publication-title: AIDS doi: 10.1097/00002030-200310170-00012 contributor: fullname: C Staehelin – ident: 2752_CR16 – volume: 45 start-page: 1093 issue: 8 year: 2007 ident: 2752_CR20 publication-title: Clin Infect Dis doi: 10.1086/521150 contributor: fullname: R Subbaraman – volume: 24 start-page: 393 issue: 3 year: 2008 ident: 2752_CR17 publication-title: AIDS Res Hum Retrovir doi: 10.1089/aid.2007.0219 contributor: fullname: C Laurent – volume: 48 start-page: 334 issue: 3 year: 2008 ident: 2752_CR9 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e31817ae5ef contributor: fullname: S Rosen – volume: 17 start-page: S4 issue: 1 year: 1998 ident: 2752_CR10 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/00042560-199801001-00003 contributor: fullname: RA Coutinho – ident: 2752_CR27 doi: 10.1186/1471-2334-14-90 – volume: 14 start-page: 53 year: 2013 ident: 2752_CR11 publication-title: HIV MEDICINE doi: 10.1111/hiv.12055 contributor: fullname: W Elamin – volume: 50 start-page: 416 issue: 3 year: 2010 ident: 2752_CR7 publication-title: Clin Infect Dis doi: 10.1086/649884 contributor: fullname: MA Bender – volume: 37 start-page: S30 issue: Suppl 1 year: 2004 ident: 2752_CR21 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/01.qai.0000137004.63376.27 contributor: fullname: G McComsey – volume: 20 start-page: 1407 year: 2006 ident: 2752_CR22 publication-title: AIDS doi: 10.1097/01.aids.0000233574.49220.de contributor: fullname: JM Llibre – ident: 2752_CR25 doi: 10.1002/14651858.CD008651 |
SSID | ssj0017829 |
Score | 2.2300782 |
Snippet | There is limited information on patterns of treatment change among new initiators of highly active antiretroviral therapy (HAART) in the regions most affected... Abstract Background There is limited information on patterns of treatment change among new initiators of highly active antiretroviral therapy (HAART) in the... |
SourceID | doaj pubmedcentral gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 664 |
SubjectTerms | Acquired Immunodeficiency Syndrome - drug therapy Adult Aged AIDS (Disease) Analysis Anti-HIV Agents - therapeutic use Antiretroviral Therapy, Highly Active - statistics & numerical data Care and treatment Cohort Studies Demographic aspects Female Ghana Highly active antiretroviral therapy HIV infection HIV Infections - drug therapy HIV Infections - mortality HIV/aids Humans Kaplan-Meier Estimate Male Middle Aged Policy change Retrospective Studies Stavudine - therapeutic use Tenofovir - therapeutic use Trends Utilization Young Adult Zidovudine - therapeutic use |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxQxFA_Sg3gR6-dqlSCCIIRuJskk8bZ-rLtCFawtvYVMPmovs7I7PfS_9yWTHZqDeBHmlPwGJnkfeW_y8gtCbygYWDcPjsg57Qin3BJlmSXeax4Vc43y6T_kybd2dca_XoiLW1d9pZqwkR54nLh0pZakVijrFDjSJmjH554HxxunWFSj96Vin0yV_QNY93TZw6SqPd6BF5apLkiSRgoIKatVKJP1Ty55WojqIslbq87yAbpfwkW8GD_zEN0J_UN096RsiD9CwxK8FbkBdcVDrm7FVz2eisfxeKw3N1p4EtcGTlfibge8iXi1Pj9erD-d4kKumnFf4BX7Hlu8DcN2sz-IuX8rs9E-RmfLzz8_rki5SIE4iGcGwoMKiadMRK0cdSxaymgIc0-V89p7FYVM5aQhRtGBFQelfWy81gAIQXXsCTroN314hrC2AGgdcwESkS62ivHYWSGjjk6JQGfo3X5ize-RL8PkPEO1ZpSCASmYJAUjZ-hDmvoJmKiucwMogCkKYP6lADP0OgnOJDKLPlXLXNrr3c6sv5-bRY4eaSvZ30CnPyrQ2wKKGxC5s-WEAow8kWRVyKMKCSbpqu6no-5MI4O0ttXQOUOy0qpq6HVPf_Urs32nDFVo9fx_zNULdK9JRpAKIJojdDBsr8NLCKqG7lW2nz9GpR-8 priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1ti9QwEA7nCeIX8f1WTwkiCEK9TZM0iSCyvqy7wip47nHfQpqX80Dau24PvH_vJO1WC3fQT-mTQjIzmUkzeQahlwQMrJx6m4kpKTNGmMmkoSZzTrEgqc2li_8hV9-KxZp9PebHO2hb3qqfwM2VW7tYT2rd_H7z5_zyPRj8u2TwsjjYwBorYtaPyHLBIWC8gW7mjLKo8Cv271ABnKHqDzav7BaJgaUqFFdk5KUSmf-wZA-OapxE-Z9Xmt9Fd_pwEs86-d9DO766j26t-gPzB6idw2qWXYI64zZlv-LTCg_J5bi79psaDTyRiwPHkrlNi-uAF8ujg9ny0yHuyVcT7gt0MW-xwY1vm3p7UXPbK7HVPkTr-eefHxdZX2ghsxDvtBnz0kceMx6UtMTSYAgl3k8dkdYp52TgIqab-hB4CVbupXIhd0oBwHtZ0kdot6orv4ewMgAoLLUeNiplKCRloTRcBBWs5J5M0OvtxOqzjk9Dp32ILHQnEA0C0VEgWkzQhzj1AzBSYaeGujnRvWVpU5aCGC6NleBpc68smzrmLcutpEHmE_QiCk5HsosqZtOcmIvNRi-_H-lZii5JIeh1oMMfI9CrHhRqELk1_Q0GGHkk0Roh90dIMFk7ev24051hZFu9myAx0qrR0MdvqtNfiQ087mC5kk-u_eZTdDuPSh6zHvJ9tNs2F_4ZRFJt-TzZx1_X9RnA priority: 102 providerName: Scholars Portal |
Title | Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28969591 https://pubmed.ncbi.nlm.nih.gov/PMC5625598 https://doaj.org/article/abb71a58ac88472e9c40d4ec42c83f82 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELXaHhAXRPlcKJWFkJCQ0qzjOLa5bQvLLtICamlVcbEcx25XokmVTQ_994y9TkQOXJCiHJJnKc7MeMbx8wtC7wgEWDm1JuFTUiY5yXUiNNVJVcncCWoyUfnvkKtvxeI8_3rJLncQ6_fCBNK-KddH9e-bo3p9HbiVtzcm7Xli6Y_ViS_amRTpLtrllPZT9Lh0AClPxuVLIop0AwMw95QgnmScQTXp5X-FLCSTZJSLgmT_MDAP6WhMlfwr98wfo0exaMSz7cPtox1bP0EPVnFZ_Cnq5jBmJffgtLgLHFe8rvFAIcfbzb3hoobDK25g_2PctsONw4vlRTpbfjrDUWI14L5AE_0Ra9zarm367Zh9q6BJ-wydzz__PFkk8XcKiYGqpktyK6xXK2NOCkMMdZpQYu20IsJUsqqEY9yTSq1zrIRYtkJWLqukBIC1oqTP0V7d1PYlwlIDoDDUWJiOlK4QNHelZtxJZwSzZII-9C9W3W5VM1SYbYhCbQ2iwCDKG0TxCTr2r34AesHrcKFpr1Q0u9JlyYlmQhsB-TSz0uTTKrcmz4ygTmQT9NYbTnlJi9pzZq703Wajlt8v1CzUkKTg9F-gs9MR6H0EuQZMbnTcpwA991JZI-TBCAmBaUa3X2x9Z-hZ73cTxEdeNer6-A6EQND8ji7_6r9bvkYPMx8EnvuQHaC9rr2zb6Ce6srD8B0CzqtcwPn0-NdhiKg_jykitA |
link.rule.ids | 230,315,733,786,790,870,891,2115,24346,27955,27956,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELVKkYAL34WFAhZCQkLKZp3Eic1tKSy70C2ItqveLNuxywqaVNnsAX49Y-dDBIkDSDnFz1KcmfGM4-cXhF4QCDA1MTrIJkQFCUlkwGQsgzzniWWxjljuvkMuj9L5afLhjJ7tINqdhfGkfa3W4-L7xbhYf_XcyssLHXY8sfDz8sAV7ZSz8Aq6CvEa0W6R3m4eQNLj7QYmYWm4gSk4c6SgLIgyCvWkEwBmPOWUk0E28qL9_dTcJ6QhWfK37DO7hVbdczekk2_jba3G-ucfko7_PLDb6GZbj-Jp03wH7ZjiLrq2bHfc76F6BtNh8APiAdeePovXBe7Z6bg5N-xvSricmAd2_9ytalxaPF-swuni7TFu1Vs97j10ka-xxJWpq7I76dn18nK399Hp7N3JwTxo_9QQaCiY6iAxzDghNGo500THVpKYGDPJCdM5z3Nmaeb4qsZaqmCaMIznNso5B4AxTMV7aLcoC_MQYS4BkOpYG1jpKJuyOLFK0sxyqxk1ZIRedRYTl40gh_ALGZaKxtICLC2cpUU2Qm-cTXug09L2N8rqXLQvXkilMiIpk5pBqo4M18kkT4xOIs1iy6IReu48Qji1jMLRcc7ldrMRi08rMfXlKUmz-G-g4y8D0MsWZEvwJS3bIxAwcqfCNUDuD5AQ83rQ_KBxyn5knUOPUDZw18HQhy3ghF5OvHW6R__d8xm6Pj9ZHorDxdHHx-hG5CLNUSyifbRbV1vzBMq2Wj31QfoLs1dB1A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSBMv3C-FARZCQkJKU-dmm7eyUVqgY2JsmnixfB0VLKna9AF-PcdOUi1IvEzKU_JZinPO8TmOP39G6BWBAFMjqyM6IirKSCYjJlMZGcMzx1KdMOP_Q84Pi-lJ9vEsP7t01Fcg7Wu1GJa_Lobl4kfgVi4vdNzxxOKj-b4v2nPO4qVx8XV0A2I2od1EvV1AgMTH20VMwop4DcMw9cQgGiU0h5rSiwAzXvCck15GCsL92-F5m5T6hMlLGWhyG33v3r0hnvwcbmo11H_-kXW8UufuoFttXYrHDeQuumbLe2h33q6830f1BIbF6DfEBa4DjRYvSrxlqeNm_3C4KeHyoh7Yn727qnHl8HR2Go9nB8e4VXENuA_QRL7FEq9svaq6HZ9dqyB7-wCdTN5_259G7YkNkYbCqY4yy6wXRMsdZ5ro1EmSEmtHhjBtuDHM5dTzVq1zuYLhwjJuXGI4B4C1TKUP0U5ZlfYxwlwCoNCptjDjUa5gaeaUzKnjTrPckgF601lNLBthDhEmNKwQjbUFWFt4aws6QO-8XbdAr6kdblSrc9F-fCGVokTmTGoGKTuxXGcjk1mdJZqljiUD9NJ7hfCqGaWn5ZzLzXotZl9OxTiUqaSg6f9Ax197oNctyFXgT1q2WyGg516Nq4fc6yEh9nXv8aPGMbc965x6gGjPZXtd7z8BRwyy4q3jPblyyxdo9-hgIj7PDj89RTcTH2yeaZHsoZ16tbHPoHqr1fMQp38BtiREVA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Five-year+trends+in+treatment+changes+in+an+adult+cohort+of+HIV%2FAIDS+patients+in+Ghana%3A+a+retrospective+cohort+study&rft.jtitle=BMC+infectious+diseases&rft.au=Ankrah%2C+Daniel+N+A&rft.au=Lartey%2C+Margaret&rft.au=Mantel-Teeuwisse%2C+Aukje+K&rft.au=Leufkens%2C+Hubert+G+M&rft.date=2017-10-02&rft.eissn=1471-2334&rft.volume=17&rft.issue=1&rft.spage=664&rft_id=info:doi/10.1186%2Fs12879-017-2752-7&rft_id=info%3Apmid%2F28969591&rft.externalDocID=28969591 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |